World Thrombolytic Drug Market Research Report (～2027)
Global Thrombolytic Drug Market (up to 2027): By Type, By Category, By Distribution Channel, By Region
360iResearch predicts that the global thrombolytic drug market, which was valued at $891.34 million in 2021, will reach $1,043.49 million in 2022 and expand to $2,324.80 million by 2027, growing at a CAGR of 17.32%. This research report provides a multifaceted analysis of the global thrombolytic drug market, including sections on introduction, research methodology, executive summary, market overview, market insights, analysis by type (fibrin-specific agents, non-fibrin-specific agents), analysis by category (urokinase, alteplase, reteplase, streptokinase, t-PA), analysis by distribution channel (e-pharmacies, hospital pharmacies, retail pharmacies), regional analysis (North America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.
- Company：マーケットリサーチセンター
- Price：Other
